Earnings Outlook: Amgen likely aiming to meet, not beat, first-quarter earnings expectations

Earnings Outlook: Amgen likely aiming to meet, not beat, first-quarter earnings expectations


Two drugs will be in the limelight when Amgen Inc. reports first-quarter earnings, scheduled for Wednesday after the close. Amgen also has warned Enbrel could have a $150 million inventory reversal in the first-quarter, due to an inventory build last quarter.



from Biotech News